Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation

The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fi...

Full description

Saved in:
Bibliographic Details
Published inJournal of inflammation research Vol. 13; pp. 925 - 932
Main Authors Persson, Hans Lennart, Sioutas, Apostolos, Jacobson, Petra, Vainikka, Linda K
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2020
Taylor & Francis Ltd
Dove
Dove Medical Press
Subjects
Online AccessGet full text
ISSN1178-7031
1178-7031
DOI10.2147/JIR.S280419

Cover

Abstract The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV ) expressed as % of predicted. Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV /FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV % of predicted. Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.
AbstractList The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).BACKGROUNDThe lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.OBJECTIVEThe aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.MATERIALS AND METHODSTwenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.RESULTSOxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.CONCLUSIONLysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.
The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV ) expressed as % of predicted. Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV /FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV % of predicted. Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.
Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio &amp;lt; 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1 % of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.
Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEVi) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FE[V.sub.1]/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FE[V.sub.1]% of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP. Keywords: acridine orange, lung macrophages, BAL, COPD, LMP, pulmonary fibrosis
Hans Lennart Persson,1,2 Apostolos Sioutas,1,2 Petra Jacobson,1,2 Linda K Vainikka3,4 1Department of Respiratory Medicine in Linköping, Linköping University, Linköping, Sweden; 2Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 3Department of Experimental Pathology, Linköping University, Linköping, Sweden; 4Department of Biomedical and Clinical Sciences, Linköping University, Linköping, SwedenCorrespondence: Hans Lennart PerssonDepartment of Respiratory Medicine in Linköping, Linköping University, Linköping SE-581 85, SwedenTel +46 010 1033621Email lennart.persson@liu.seBackground: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL).Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted.Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded.Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted.Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.Keywords: acridine orange, lung macrophages, BAL, COPD, LMP, pulmonary fibrosis
Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by oxidant challenge in vivo lysosomes may rupture in LMs and leakage of cellular content and cell debris may trigger airway inflammation and fibrosis, which may lead to chronic airflow limitation (CAL). Objective: The aim of this study was to determine whether lysosomal membrane permeabilization (LMP) in LMs challenged to oxidants ex vivo is associated with airway inflammation and CAL, the latter assessed as the reduced forced expiratory volume in one second (FEV1) expressed as % of predicted. Materials and Methods: Twenty-eight subjects were investigated; 13 lung-healthy subjects and 15 subjects with a variety of inflammatory disorders, demonstrating CAL on dynamic spirometry (defined as an FEV1/FVC ratio < 0.70). LMs were harvested by broncho-alveolar lavage (BAL) and challenged ex vivo by oxidants. LMP in oxidant-exposed LMs was assessed as the emitted acridine orange (AO) green fluorescence from oxidant-exposed LMs (using macrophage-like murine J774 cells as positive controls). Inflammatory cells in BAL were counted and lung volumes were recorded. Results: Oxidant-induced LMP in LMs was significantly greater among subjects with CAL and particularly among those with ongoing inflammation. Previous tobacco history did not influence LMP. Among subjects with CAL, oxidant-induced LMP correlated negatively with FEV1% of predicted. Conclusion: Lysosomes of LMs harvested from patients with CAL demonstrate an increased sensitivity to oxidants, which may trigger mechanisms behind CAL, eg, chronic airway inflammation and fibrotic re-modelling. The study suggests a mechanistic role for LMP in LMs on airway inflammation, suggesting an anti-inflammatory effect by drugs that prevent increased LMP.
Audience Academic
Author Persson, Hans Lennart
Vainikka, Linda K
Jacobson, Petra
Sioutas, Apostolos
Author_xml – sequence: 1
  givenname: Hans Lennart
  orcidid: 0000-0002-5700-7284
  surname: Persson
  fullname: Persson, Hans Lennart
– sequence: 2
  givenname: Apostolos
  surname: Sioutas
  fullname: Sioutas, Apostolos
– sequence: 3
  givenname: Petra
  surname: Jacobson
  fullname: Jacobson, Petra
– sequence: 4
  givenname: Linda K
  orcidid: 0000-0002-4371-1238
  surname: Vainikka
  fullname: Vainikka, Linda K
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33235481$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-171981$$DView record from Swedish Publication Index
BookMark eNptk11v0zAUhiM0xMbYFffIEhJCQh124sQ2F0hV-VhRp0kMuLVOHbv15NglTrqNH8LvxVnL1E5LLmL5POc98fF7nmcHPnidZS8JPs0JZe-_Tb-fXuYcUyKeZEeEMD5iuCAHO-vD7CTGKzw8DNOcPssOiyIvSsrJUfb3rG_Ao1nvF-gcVBtWS1joiCZLcE77ha5RF9DFja3BdxHpG7S26_ABzW5jiKEBh851M2_Ba3SpfbSd_QOdDR7ZiMYxBmWhSxrXtluiqTcOmmYTB1-nIm3wVqGxbY0L12hmG9vdhV9kTw24qE-23-Ps55fPPyZno9nF1-lkPBupipBuxECI2sxrUiiOhTBzQTkuSoFLXVFTzY0wgI0oqlIBq0yZV5zXqtA0rwhUuCyOs-lGtw5wJVetbaC9lQGsvNsI7UJC21nltKwrmuesgNRSoJoXwBXjYAibU8J1TpPWaKMVr_Wqn--pfbK_xndqzvaSMCI4SfzHDZ_gRtdK-64Ft5e2H_F2KRdhLVnFOM9xEni7FWjD717HTjY2Ku1cuo3QR5nTKtkip3io9foBehX61qfWDhQWrKJih1pAOrD1JqS6ahCV44qWXNCyGM55-giV3lo3ViV7Gpv29xLe7CQsNbhuGYPrh4uO--Cr3Y7ct-K_XRPwbgMko8bYanOPECyHeZBpHuR2HhJNHtBqa6_0w9Y9mvMP4IYMIA
CitedBy_id crossref_primary_10_3390_mps6040072
crossref_primary_10_2147_JIR_S366204
crossref_primary_10_1016_j_jid_2023_01_036
crossref_primary_10_3390_md22120561
crossref_primary_10_1128_spectrum_00995_23
crossref_primary_10_2147_COPD_S425592
Cites_doi 10.1186/s12931-020-01381-5
10.1016/j.imbio.2017.11.001
10.1016/0005-2736(91)90238-4
10.1177/1753466619890538
10.1007/s00281-016-0555-3
10.1186/s12931-017-0695-6
10.2147/JIR.S128292
10.1016/j.freeradbiomed.2018.07.024
10.1186/s12931-017-0699-2
10.3390/jcm6020021
10.1016/j.toxlet.2005.05.002
10.1183/09031936.00044108
10.3389/fimmu.2018.01777
10.1164/rccm.201202-0320ST
10.1016/S0891-5849(03)00109-6
10.1089/ars.2012.4785
10.12688/f1000research.11236.2
10.21037/jtd.2019.10.43
10.1517/13543784.14.8.997
10.1186/s12931-018-0756-5
10.1378/chest.10-0818
10.4137/JCD.S13271
10.1186/1465-9921-13-83
10.14814/phy2.13584
10.1152/ajplung.00518.2016
10.1042/0264-6021:3560549
10.1093/toxsci/kfy309
10.2147/COPD.S233506
10.1136/thoraxjnl-2012-201761
10.2147/COPD.S81032
ContentType Journal Article
Copyright 2020 Persson et al.
COPYRIGHT 2020 Dove Medical Press Limited
2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 Persson et al. 2020 Persson et al.
Copyright_xml – notice: 2020 Persson et al.
– notice: COPYRIGHT 2020 Dove Medical Press Limited
– notice: 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 Persson et al. 2020 Persson et al.
DBID AAYXX
CITATION
NPM
3V.
7RV
7XB
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
KB0
LK8
M2O
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
DOA
DOI 10.2147/JIR.S280419
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SWEPUB Linköpings universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Linköpings universitet
SwePub Articles full text
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed




Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Persson et al
EISSN 1178-7031
EndPage 932
ExternalDocumentID oai_doaj_org_article_d642273a703a4e83a8c78af17b418e24
oai_DiVA_org_liu_171981
PMC7678820
A645894534
33235481
10_2147_JIR_S280419
Genre Journal Article
GeographicLocations Sweden
United Kingdom--UK
GeographicLocations_xml – name: Sweden
– name: United Kingdom--UK
GroupedDBID ---
0YH
29K
2WC
53G
5VS
7RV
8FE
8FH
8FI
8FJ
8G5
AAYXX
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
CITATION
D-I
DIK
DWQXO
E3Z
EBD
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
IHW
IPNFZ
ITC
KQ8
LK8
M2O
M48
M7P
M~E
NAPCQ
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TDBHL
TR2
UKHRP
VDV
NPM
PMFND
3V.
7XB
8FK
MBDVC
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ABXSW
ADTPV
AOWAS
D8T
DG8
ZZAVC
ID FETCH-LOGICAL-c611t-7a99dfbd13c8099fb948035905e64f6bf9fa0f9365ca76f52688dc3e4261a6053
IEDL.DBID M48
ISSN 1178-7031
IngestDate Wed Aug 27 01:14:15 EDT 2025
Tue Sep 09 23:43:18 EDT 2025
Thu Aug 21 13:52:32 EDT 2025
Thu Sep 04 23:53:21 EDT 2025
Fri Jul 25 11:55:38 EDT 2025
Tue Jun 17 21:12:07 EDT 2025
Tue Jun 10 20:16:07 EDT 2025
Thu May 22 21:06:37 EDT 2025
Thu Jan 02 22:54:15 EST 2025
Tue Jul 01 03:13:47 EDT 2025
Thu Apr 24 23:04:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords BAL
LMP
acridine orange
lung macrophages
pulmonary fibrosis
COPD
Language English
License http://creativecommons.org/licenses/by-nc/3.0
2020 Persson et al.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c611t-7a99dfbd13c8099fb948035905e64f6bf9fa0f9365ca76f52688dc3e4261a6053
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5700-7284
0000-0002-4371-1238
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/JIR.S280419
PMID 33235481
PQID 2460976491
PQPubID 3933408
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_d642273a703a4e83a8c78af17b418e24
swepub_primary_oai_DiVA_org_liu_171981
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7678820
proquest_miscellaneous_2464192401
proquest_journals_2460976491
gale_infotracmisc_A645894534
gale_infotracacademiconefile_A645894534
gale_healthsolutions_A645894534
pubmed_primary_33235481
crossref_primary_10_2147_JIR_S280419
crossref_citationtrail_10_2147_JIR_S280419
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-01-01
PublicationDateYYYYMMDD 2020-01-01
PublicationDate_xml – month: 01
  year: 2020
  text: 2020-01-01
  day: 01
PublicationDecade 2020
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
– name: Macclesfield
PublicationTitle Journal of inflammation research
PublicationTitleAlternate J Inflamm Res
PublicationYear 2020
Publisher Dove Medical Press Limited
Taylor & Francis Ltd
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Taylor & Francis Ltd
– name: Dove
– name: Dove Medical Press
References Yu (ref26) 2003; 34
Yang (ref4) 2018; 19
Liao (ref8) 2019; 13
Persson (ref12) 2013; 6
Laskin (ref22) 2019; 168
Brown (ref2) 2020; 21
Wang (ref24) 2020; 15
Grabiec (ref19) 2016; 38
Fan (ref23) 2018; 19
Arora (ref21) 2018; 223
Weidner (ref5) 2018; 6
Aja (ref6) 2017; 6
Persson (ref28) 2011; 139
Persson (ref27) 2009; 33
Yang (ref3) 2018; 19
Persson (ref9) 2005; 14
Sioutas (ref13) 2017; 10
Milara (ref14) 2013; 68
Mahmood (ref15) 2015; 10
Hikichi (ref1) 2019; 11
Meyer (ref18) 2012; 185
Hodge (ref25) 2017; 312
Persson (ref11) 2012; 13
Zhang (ref7) 2019; 133
Mattsson (ref17) 1991; 1065
Brüne (ref30) 2013; 19
Kota (ref16) 2017; 6
Antunes (ref29) 2001; 356
Persson (ref10) 2005; 159
Allard (ref20) 2018; 9
References_xml – volume: 21
  start-page: 111
  year: 2020
  ident: ref2
  publication-title: Respir Res
  doi: 10.1186/s12931-020-01381-5
– volume: 223
  start-page: 383
  year: 2018
  ident: ref21
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2017.11.001
– volume: 1065
  start-page: 261
  year: 1991
  ident: ref17
  publication-title: Biochim Biophys Acta
  doi: 10.1016/0005-2736(91)90238-4
– volume: 13
  start-page: 1753466619890538
  year: 2019
  ident: ref8
  publication-title: Ther Adv Respir Dis
  doi: 10.1177/1753466619890538
– volume: 38
  start-page: 409
  year: 2016
  ident: ref19
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-016-0555-3
– volume: 19
  start-page: 40
  year: 2018
  ident: ref3
  publication-title: Respir Res
  doi: 10.1186/s12931-017-0695-6
– volume: 10
  start-page: 29
  year: 2017
  ident: ref13
  publication-title: J Inflamm Res
  doi: 10.2147/JIR.S128292
– volume: 133
  start-page: 238
  year: 2019
  ident: ref7
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2018.07.024
– volume: 19
  start-page: 39
  year: 2018
  ident: ref4
  publication-title: Respir Res
  doi: 10.1186/s12931-017-0699-2
– volume: 6
  start-page: 21
  year: 2017
  ident: ref6
  publication-title: J Clin Med
  doi: 10.3390/jcm6020021
– volume: 159
  start-page: 124
  year: 2005
  ident: ref10
  publication-title: Toxicol Lett
  doi: 10.1016/j.toxlet.2005.05.002
– volume: 33
  start-page: 673
  year: 2009
  ident: ref27
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00044108
– volume: 9
  start-page: 1777
  year: 2018
  ident: ref20
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01777
– volume: 185
  start-page: 1004
  year: 2012
  ident: ref18
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201202-0320ST
– volume: 34
  start-page: 1243
  year: 2003
  ident: ref26
  publication-title: Free Radic Biol Med
  doi: 10.1016/S0891-5849(03)00109-6
– volume: 19
  start-page: 595
  year: 2013
  ident: ref30
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2012.4785
– volume: 6
  start-page: 409
  year: 2017
  ident: ref16
  publication-title: Res
  doi: 10.12688/f1000research.11236.2
– volume: 11
  start-page: S2129
  year: 2019
  ident: ref1
  publication-title: J Thorac Dis
  doi: 10.21037/jtd.2019.10.43
– volume: 14
  start-page: 997
  year: 2005
  ident: ref9
  publication-title: Expert Opin Investig Drugs
  doi: 10.1517/13543784.14.8.997
– volume: 19
  start-page: 50
  year: 2018
  ident: ref23
  publication-title: Respir Res
  doi: 10.1186/s12931-018-0756-5
– volume: 139
  start-page: 361
  year: 2011
  ident: ref28
  publication-title: Chest
  doi: 10.1378/chest.10-0818
– volume: 6
  start-page: 69
  year: 2013
  ident: ref12
  publication-title: J Cell Death
  doi: 10.4137/JCD.S13271
– volume: 13
  start-page: 83
  year: 2012
  ident: ref11
  publication-title: Respir Res
  doi: 10.1186/1465-9921-13-83
– volume: 6
  start-page: e13584
  year: 2018
  ident: ref5
  publication-title: Physiol Rep
  doi: 10.14814/phy2.13584
– volume: 312
  start-page: L678
  year: 2017
  ident: ref25
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00518.2016
– volume: 356
  start-page: 549
  year: 2001
  ident: ref29
  publication-title: Biochem J
  doi: 10.1042/0264-6021:3560549
– volume: 168
  start-page: 287
  year: 2019
  ident: ref22
  publication-title: Toxicol Sci
  doi: 10.1093/toxsci/kfy309
– volume: 15
  start-page: 1093
  year: 2020
  ident: ref24
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S233506
– volume: 68
  start-page: 410
  year: 2013
  ident: ref14
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2012-201761
– volume: 10
  start-page: 1515
  year: 2015
  ident: ref15
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S81032
SSID ssj0000070424
Score 2.1763155
Snippet The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon cellular stress by...
Background: The lung macrophage (LM) is involved in most inflammatory processes of the human lung by clearance of dying cells and by wound repair. Upon...
Hans Lennart Persson,1,2 Apostolos Sioutas,1,2 Petra Jacobson,1,2 Linda K Vainikka3,4 1Department of Respiratory Medicine in Linköping, Linköping University,...
SourceID doaj
swepub
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 925
SubjectTerms Acridine orange
Alveoli
Asthma
Autophagy
bal
Bronchoscopy
Cellular stress response
Chronic obstructive pulmonary disease
copd
Experiments
Fibroblasts
Fibrosis
Fluorescence
Inflammation
Inflammatory diseases
lmp
Lung diseases
Lung diseases, Obstructive
lung macrophages
Lungs
Lysosomes
Macrophages
Original Research
Oxidants
Oxidative stress
pulmonary fibrosis
Respiratory tract
Respiratory tract diseases
Sarcoidosis
Smoking
Spirometry
Tobacco
Wound healing
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4s2WFoxUgYQUuo7zsLkthaqtuiBRinqzHMdWI22TqsmW8kf4vczY2WgDSFy4xmMr9ow9M_bMN4TsFE5wx6Y2YrE2EWg8ERWg5yKuRQoKyDlpfYDsp-zgNDk6S8_WSn1hTFiABw4Lt1uCgQwqVoNk6sQKGMPkQjuWFwkTNvZIoKDG1pypYPjm-KYXKquICEHaQ3IeluXZPTr88vYkRuQdOVJHHrX_z7N5TTn9Hjg5ghf1Kmn_Hrnb25J0FuZwn9yy9QNye96_lj8kP_0NPT2G_UznGmt1ncPp0dK9VQGVknYN_XxTlRgMQ-0Nva6um3f0-EfbtM0FDD23F-BN15aeYJx71-ds0qqlK7bCGHiVSw9rB7IV8iCprkvao-7SWXXlFs136jOpfPMjcrr_8eveQdTXYYhMxlgX5VrK0hUl40aAQekKmQhE_pumNktcVjjp9NRJnqVG55lDABlRGm7RO9PgLvHHZKNuavuU0NJaETsmNfidSZ4VQpiSpzpndmoKw9mEvFmxQ5n-r7BWxkKBs4K8U8A71fNuQnYG4suAzfF3svfI14EEAbX9BxAz1YuZ-peYTcgLlAoVslOHY0HNsiQVMkk5ULz2FHgwwC8b3ec3wMQRYmtEuTWihA1txs0ryVP9gdKqOMmmYDkmEpbo5dCMPTFIrrbN0tPgmz54zBPyJAjqMGnOYw7OKbTkIxEercq4pa7OPdx4DvYM2IkT8ioI-6jLh-rbzC_koloqljMp2Ob_WO9n5E6MNxv-smuLbHRXS7sN5l9XPPc7_ReydFbe
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ta9RAEF7qFcQv4rvRqisUBSH2NrtJNoLItba0pVeltdJvYbPZtYFrUu-l1j_i73VmszmNil-zk5BkZudtZ54hZL2wkls2NCGLlA7B4smwADsXciVjMEDWZsYVyB4muydi_zQ-XSGHXS8MllV2OtEp6rLRmCPfiEQyBNMpMvbu4muIU6PwdLUboaH8aIXyrYMYu0ZWI5yqPCCrm9uHH4-WWRdEtxGRaBv1cETPxv7e0evjCFF4sp5pcgj-f-vp3wzVn0WUPahRZ552bpGb3q-ko1YQbpMVU98h18f-5Pwu-eGy9fQA9jYdK5zbdQaaZEa3umEqJZ039MNVVWJhDDVX9LK6bN7Qg--zZtacw6PH5hwi69rQY6x5n_v-TVrNaMdieAamdelebUHO2p5IquqSegReOqqmdtJ8o66ryi3fIyc725-2dkM_kyHUCWPzMFVZVtqiZFxLcC5tkQmJKIDD2CTCJoXNrBrajCexVmliEUxGlpobjNQUhE78PhnUTW0eEloaIyPLMgUxqEiTQkpd8lilzAx1oTkLyKuOHbn2b4VzMyY5BC7Iuxx4l3veBWR9SXzR4nT8m2wT-bokQXBtd6GZfsn9Xs1LiMnAq1OgDJUwEsRWp1JZlhaCSROJgDxDqcjbTtWlishHiYhlJmIOFC8dBSoJeGWtfK8DfDjCbfUo13qUsLl1f7mTvNwrl1n-aysE5PlyGe_EgrnaNAtHg-f7ED0H5EErqMuP5jziEKjCStoT4d5f6a_U1ZmDHk_BtwGfMSAvWmHv3fK--jxyP3JSLXKWskyyR_9__8fkRoT5C5fSWiOD-XRhnoCTNy-e-p37E38jU9I
  priority: 102
  providerName: ProQuest
Title Human Lung Macrophages Challenged to Oxidants ex vivo: Lysosomal Membrane Sensitization is Associated with Inflammation and Chronic Airflow Limitation
URI https://www.ncbi.nlm.nih.gov/pubmed/33235481
https://www.proquest.com/docview/2460976491
https://www.proquest.com/docview/2464192401
https://pubmed.ncbi.nlm.nih.gov/PMC7678820
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-171981
https://doaj.org/article/d642273a703a4e83a8c78af17b418e24
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: DIK
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: GX1
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: M~E
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: RPM
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: BENPR
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: M48
  dateStart: 20080901
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
– providerCode: PRVAWR
  databaseName: Taylor & Francis Open Access
  customDbUrl:
  eissn: 1178-7031
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000070424
  issn: 1178-7031
  databaseCode: 0YH
  dateStart: 20080901
  isFulltext: true
  titleUrlDefault: https://www.tandfonline.com
  providerName: Taylor & Francis
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3db9MwELfGJiFeEN90G8VIE0hIGXXsJA4SQt3Y2KZ1oI1OfYscx2aRugT6Mbp_hL-XOyepyJjESx_qc5T4fue7s--DkK3USm5Zz3jMV9oDjSe9FPScx5UMQAFZGxsXIHsSHgzF0SgYrZCmGWe9gNNbXTvsJzWcjLcXP68_gsB_wDBmJqJ3R4en22c-FtKJ75A1UEk-wntQ2_mVHRzhFV_VaEV6WLO9ytW7Ob-lnVwR_3-36r901c04yla1Uaeh9h-Q-7VpSfsVFh6SFVM8IncH9eX5Y_LbHdjTYxBvOlDYuusCNpMp3W36qWR0VtIvizzD2BhqFvQqvyrf0-PraTktL-HRA3MJznVh6BmGvc_qFE6aT2nDZXgGnuzSw8IC1Kq0SKqKjNZFeGk_n9hx-Yu6xCo3_IQM9_e-7R54dVsGT4eMzbxIxXFm04xxLcG-tGksJBYC7AUmFDZMbWxVz8Y8DLSKQov1ZGSmuUFnTYH3xJ-S1aIszHNCM2Okb1mswA0VUZhKqTMeqIiZnk41Zx3ytmFHouu3wtYZ4wR8F-RdArxLat51yNaS-EdVquN2sh3k65IE62u7P8rJ96QW1yQDtwwMOwVIUcJIQK6OpLIsSgWTxhcd8hJRkVTJqstdIumHIpCxCDhQvHEUiFx4Za3qdAf4cKy41aLcbFGCfOv2cIO8pBGPxBdhDwxJEcMSvVoO40yMmStMOXc0eMUPDnSHPKuAuvxozn0OviqMRC0It1alPVLkF676eATmDZiNHfK6Antryqf8vO8WcpzPExaxWLL1_y7VBrnn4ymGO9jaJKuzydy8AFNvlnbJ2s7eydfTrjsqgd_PI9Z1ov0HWmZVrQ
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwELZKKwEviJuFQo1UQEIKXcdO4iBVaHtpt91dUA_Ut-A4No20TcoePf4IP4ffxthxFgKIt77GE8vJjOewZ75BaDXVnGrSVh7xhfTA4nEvBTvnUcEDMEBax8omyA7D7hHbPQ6OF9CPuhbGpFXWOtEq6qyU5ox8zWdhG0wni8mHs2-e6RplblfrFhrCtVbI1i3EmCvs2FNXFxDCTdZ7W8DvV76_s3242fVclwFPhoRMvUjEcabTjFDJwV3Sacy4wbVrBypkOkx1rEVbxzQMpIhCbeBReCapMrGHgGCAwrw30BK4HRR21dLG9vDT_vyUx6DpMJ9VhYGmJdDabm__3YFvUH_ihim0HQP-tgu_GcY_kzYb0KbWHO7cRXecH4s7leDdQwuquI9uDtxN_QP03d4O4D7oEjwQpk_YCWiuCd6sm7dkeFrij5d5ZhJxsLrE5_l5-R73ryblpDyFqQfqFCL5QuEDk2M_dfWiOJ_gWqRgDnOMjHuFBrmuajCxKDLsEH9xJx_rUXmBbRWXHX6Ijq6FO4_QYlEW6gnCmVLc1yQWEPOyKEw5lxkNRERUW6aSkhZ6W7MjkW5Vpk_HKIFAyfAuAd4ljncttDonPqtwQf5NtmH4OicxYN72QTn-mjjdkGQQA4IXKUD5CqY4bBMZcaFJlDLClc9aaMVIRVJVxs5VUtIJWcBjFlCgeGMpjFKCJUvhaivgww28V4NyuUEJykQ2h2vJS5wymyS_tl4LvZwPmzdNgl6hypmlMfkEEK230ONKUOcfTalPITCGkaghwo2_0hwp8hMLdR6BLwU-agu9roS98cpW_rljf-QonyUkIjEnT_-__hV0q3s46Cf93nDvGbrtm7MTe5y2jBan45l6Dg7mNH3hdjFGX65bcfwEKRaQAw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELVKK1W8IO4sFGqkAhJS2HXiJA5ShbbdVt3eqFqK-hYcx6aR2qTsbm8_wkfxVcw4zkIA8dbXeGI5mfGZGXsuhCxlRgSG9bTHfKk80HjCy0DPeYEUISggYxJtA2R3o41DvnkUHs2QH00uDIZVNphogTqvFJ6Rd30e9UB18oR1jQuL2Busfzj75mEHKbxpbdppSNdmIV-25cZckseWvr4Ed268PBwA71_5_vrap9UNz3Uc8FTE2MSLZZLkJstZoASYTiZLuMAad71QR9xEmUmM7JkkiEIl48hgqRSRq0CjHyLBMQhg3ltkLsZ80Vkyt7K2u7c_PfHByjrc53WSILYH6m4O998d-FgBKGmpRds94G8d8ZuS_DOAs1Xm1KrG9bvkjrNpab8WwntkRpf3yfyOu7V_QL7bmwK6DbhCdyT2DDsGFBvT1aaRS04nFf14VeQYlEP1Fb0oLqr3dPt6XI2rU5h6R5-CV19qeoDx9hOXO0qLMW3EC-bAI2U6LA3IeJ2PSWWZU1f9l_aLkTmpLqnN6LLDD8nhjXDnEZktq1I_ITTXWviGJRL8Xx5HmRAqD0IZM91TmQpYh7xt2JEqtyrs2XGSgtOEvEuBd6njXYcsTYnP6hoh_yZbQb5OSbCwt31Qjb6mDifSHPxBsCglALHkWsCWUbGQhsUZZ0L7vEMWUSrSOkt2Ck9pP-KhSHgYAMUbS4EABUtW0uVZwIdjqa8W5UKLEoBFtYcbyUsdsI3TX9uwQ15Oh_FNDNYrdXVuaTC2ADz3DnlcC-r0o4PAD8BJhpG4JcKtv9IeKYtjW_Y8BrsK7NUOeV0Le-uVQfG5b3_kSXGespglgj39__oXyTwASLo93N16Rm77eIxiT9YWyOxkdK6fg605yV64TUzJl5vGjZ_uK5Q9
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Human+Lung+Macrophages+Challenged+to+Oxidants+ex+vivo%3A+Lysosomal+Membrane+Sensitization+is+Associated+with+Inflammation+and+Chronic+Airflow+Limitation&rft.jtitle=Journal+of+inflammation+research&rft.au=Sioutas%2C+Apostolos&rft.au=Jacobson%2C+Petra&rft.au=Persson%2C+Hans+Lennart&rft.au=Vainikka%2C+Linda+K&rft.date=2020-01-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-7031&rft.eissn=1178-7031&rft.volume=13&rft.spage=925&rft_id=info:doi/10.2147%2FJIR.S280419&rft.externalDBID=n%2Fa&rft.externalDocID=A645894534
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-7031&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-7031&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-7031&client=summon